Literature DB >> 11761507

Step care therapy for hypertension in diabetic patients.

J L Blackshear1, G L Schwartz.   

Abstract

For diabetic patients, a goal blood pressure lower than 130/80-85 mm Hg is strongly supported by clinical trial results. We review the agents, sequence, and dosing used in clinical trials and propose a treatment algorithm. Multiagent antihypertensive therapy is required to attain goal blood pressure in most patients. Step sequences to obtain this goal are suggested. In general, we favor initial therapy with an angiotensin-converting enzyme inhibitor, followed by the addition of a diuretic. The presence of comorbid conditions may dictate variation from this scheme. The effect of antihypertensive agents on established cardiovascular diseases, proteinuria, renal function, and metabolic factors is discussed. Tailored recommendations for specific clinical scenarios are described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11761507     DOI: 10.4065/76.12.1266

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.

Authors:  S Oparil; S G Chrysant; M Melino; J Lee; S Karki; R Heyrman
Journal:  J Hum Hypertens       Date:  2010-03-04       Impact factor: 3.012

2.  Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.

Authors:  Steven G Chrysant; Suzanne Oparil; Michael Melino; Sulekha Karki; James Lee; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

3.  Algorithms for optimizing drug therapy.

Authors:  Peter Wanger; Lene Martin
Journal:  BMC Med Inform Decis Mak       Date:  2004-07-20       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.